| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | calcium ion binding | ZZEF1 PCDH11X PCDHB1 NPNT UNC13B VLDLR FAT4 NAALADL1 PCDHGB6 FAT3 PCDHAC2 PCDHA10 PCDHA7 PCDHA6 PCDHA4 PCDHA2 PCDHA1 DNAH7 THBS2 THBS3 ARSA CELSR2 PCDHGB4 DCHS1 LRP4 LTBP2 RASGRP2 | 2.69e-08 | 749 | 211 | 27 | GO:0005509 |
| GeneOntologyMolecularFunction | minus-end-directed microtubule motor activity | 3.30e-05 | 18 | 211 | 4 | GO:0008569 | |
| GeneOntologyMolecularFunction | dynein light intermediate chain binding | 2.03e-04 | 28 | 211 | 4 | GO:0051959 | |
| GeneOntologyMolecularFunction | ATP hydrolysis activity | ABCA2 ABCA4 ABCA13 MYO9B MCM5 RAD54L2 MDN1 ATAD2B DNAH6 SMCHD1 DNAH2 DNAH7 DHX30 YME1L1 | 2.64e-04 | 441 | 211 | 14 | GO:0016887 |
| GeneOntologyBiologicalProcess | homophilic cell adhesion via plasma membrane adhesion molecules | PLXNB2 PCDH11X PCDHB1 FAT4 PCDHGB6 FAT3 PCDHAC2 PCDHA10 PCDHA7 PCDHA6 PCDHA4 PCDHA2 PCDHA1 CELSR2 PCDHGB4 DCHS1 | 8.36e-11 | 187 | 209 | 16 | GO:0007156 |
| GeneOntologyBiologicalProcess | cell-cell adhesion via plasma-membrane adhesion molecules | DAB1 KLF4 PLXNB2 PCDH11X PCDHB1 FAT4 PCDHGB6 FAT3 PCDHAC2 PCDHA10 PCDHA7 PCDHA6 PCDHA4 PCDHA2 PCDHA1 CELSR2 PCDHGB4 DCHS1 IL1RAP | 5.10e-10 | 313 | 209 | 19 | GO:0098742 |
| GeneOntologyBiologicalProcess | cell-cell adhesion | ABL1 DAB1 ITGAE KLF4 PLXNB2 PCDH11X TJP2 AKT1 PCDHB1 NPNT FAT4 PCDHGB6 TMIGD2 FAT3 AKNA PCDHAC2 PCDHA10 PCDHA7 PCDHA6 PCDHA4 PCDHA2 PCDHA1 RUNX3 CELSR2 PCDHGB4 DCHS1 CTNNA2 IL1RAP | 4.55e-06 | 1077 | 209 | 28 | GO:0098609 |
| GeneOntologyCellularComponent | inner dynein arm | 1.98e-06 | 10 | 210 | 4 | GO:0036156 | |
| GeneOntologyCellularComponent | axonemal dynein complex | 1.06e-04 | 25 | 210 | 4 | GO:0005858 | |
| GeneOntologyCellularComponent | dynein complex | 2.07e-04 | 54 | 210 | 5 | GO:0030286 | |
| Domain | CA | FREM2 PCDH11X PCDHB1 FAT4 PCDHGB6 FAT3 PCDHAC2 PCDHA10 PCDHA7 PCDHA6 PCDHA4 PCDHA2 PCDHA1 CELSR2 PCDHGB4 DCHS1 | 2.23e-13 | 115 | 211 | 16 | SM00112 |
| Domain | Cadherin | FREM2 PCDH11X PCDHB1 FAT4 PCDHGB6 FAT3 PCDHAC2 PCDHA10 PCDHA7 PCDHA6 PCDHA4 PCDHA2 PCDHA1 CELSR2 PCDHGB4 DCHS1 | 3.36e-13 | 118 | 211 | 16 | IPR002126 |
| Domain | Cadherin_CS | PCDH11X PCDHB1 FAT4 PCDHGB6 FAT3 PCDHAC2 PCDHA10 PCDHA7 PCDHA6 PCDHA4 PCDHA2 PCDHA1 CELSR2 PCDHGB4 DCHS1 | 1.51e-12 | 109 | 211 | 15 | IPR020894 |
| Domain | CADHERIN_1 | PCDH11X PCDHB1 FAT4 PCDHGB6 FAT3 PCDHAC2 PCDHA10 PCDHA7 PCDHA6 PCDHA4 PCDHA2 PCDHA1 CELSR2 PCDHGB4 DCHS1 | 2.58e-12 | 113 | 211 | 15 | PS00232 |
| Domain | Cadherin | PCDH11X PCDHB1 FAT4 PCDHGB6 FAT3 PCDHAC2 PCDHA10 PCDHA7 PCDHA6 PCDHA4 PCDHA2 PCDHA1 CELSR2 PCDHGB4 DCHS1 | 2.58e-12 | 113 | 211 | 15 | PF00028 |
| Domain | CADHERIN_2 | PCDH11X PCDHB1 FAT4 PCDHGB6 FAT3 PCDHAC2 PCDHA10 PCDHA7 PCDHA6 PCDHA4 PCDHA2 PCDHA1 CELSR2 PCDHGB4 DCHS1 | 2.95e-12 | 114 | 211 | 15 | PS50268 |
| Domain | - | PCDH11X PCDHB1 FAT4 PCDHGB6 FAT3 PCDHAC2 PCDHA10 PCDHA7 PCDHA6 PCDHA4 PCDHA2 PCDHA1 CELSR2 PCDHGB4 DCHS1 | 2.95e-12 | 114 | 211 | 15 | 2.60.40.60 |
| Domain | Cadherin-like | PCDH11X PCDHB1 FAT4 PCDHGB6 FAT3 PCDHAC2 PCDHA10 PCDHA7 PCDHA6 PCDHA4 PCDHA2 PCDHA1 CELSR2 PCDHGB4 DCHS1 | 3.81e-12 | 116 | 211 | 15 | IPR015919 |
| Domain | Cadherin_2 | PCDH11X PCDHB1 PCDHGB6 PCDHAC2 PCDHA10 PCDHA7 PCDHA6 PCDHA4 PCDHA2 PCDHA1 PCDHGB4 | 1.55e-10 | 65 | 211 | 11 | PF08266 |
| Domain | Cadherin_N | PCDH11X PCDHB1 PCDHGB6 PCDHAC2 PCDHA10 PCDHA7 PCDHA6 PCDHA4 PCDHA2 PCDHA1 PCDHGB4 | 1.55e-10 | 65 | 211 | 11 | IPR013164 |
| Domain | Cadherin_tail | PCDHGB6 PCDHAC2 PCDHA10 PCDHA7 PCDHA6 PCDHA4 PCDHA2 PCDHA1 PCDHGB4 | 2.39e-10 | 37 | 211 | 9 | PF15974 |
| Domain | Cadherin_CBD | PCDHGB6 PCDHAC2 PCDHA10 PCDHA7 PCDHA6 PCDHA4 PCDHA2 PCDHA1 PCDHGB4 | 2.39e-10 | 37 | 211 | 9 | IPR031904 |
| Domain | Laminin_G | 2.74e-07 | 58 | 211 | 8 | IPR001791 | |
| Domain | EGF_CA | 5.79e-06 | 86 | 211 | 8 | PF07645 | |
| Domain | EGF_CA | 1.02e-05 | 122 | 211 | 9 | SM00179 | |
| Domain | EGF-like_Ca-bd_dom | 1.17e-05 | 124 | 211 | 9 | IPR001881 | |
| Domain | Dynein_heavy_chain_D4_dom | 1.45e-05 | 14 | 211 | 4 | IPR024317 | |
| Domain | Dynein_HC_stalk | 1.45e-05 | 14 | 211 | 4 | IPR024743 | |
| Domain | Dynein_heavy_dom-2 | 1.45e-05 | 14 | 211 | 4 | IPR013602 | |
| Domain | DHC_N2 | 1.45e-05 | 14 | 211 | 4 | PF08393 | |
| Domain | ATPase_dyneun-rel_AAA | 1.45e-05 | 14 | 211 | 4 | IPR011704 | |
| Domain | MT | 1.45e-05 | 14 | 211 | 4 | PF12777 | |
| Domain | AAA_8 | 1.45e-05 | 14 | 211 | 4 | PF12780 | |
| Domain | AAA_5 | 1.45e-05 | 14 | 211 | 4 | PF07728 | |
| Domain | DHC_fam | 1.96e-05 | 15 | 211 | 4 | IPR026983 | |
| Domain | Dynein_heavy | 1.96e-05 | 15 | 211 | 4 | PF03028 | |
| Domain | Dynein_heavy_dom | 1.96e-05 | 15 | 211 | 4 | IPR004273 | |
| Domain | AAA | 3.85e-05 | 144 | 211 | 9 | SM00382 | |
| Domain | AAA+_ATPase | 3.85e-05 | 144 | 211 | 9 | IPR003593 | |
| Domain | ConA-like_dom | TRIML1 LAMA1 NPNT FAT4 COL11A2 COL20A1 FAT3 TRIM27 THBS2 THBS3 CELSR2 | 4.10e-05 | 219 | 211 | 11 | IPR013320 |
| Domain | Laminin_G_2 | 8.37e-05 | 40 | 211 | 5 | PF02210 | |
| Domain | C1 | 9.18e-05 | 65 | 211 | 6 | SM00109 | |
| Domain | PE/DAG-bd | 1.00e-04 | 66 | 211 | 6 | IPR002219 | |
| Domain | - | 1.01e-04 | 95 | 211 | 7 | 2.60.120.200 | |
| Domain | Cadherin_C | 1.06e-04 | 42 | 211 | 5 | IPR032455 | |
| Domain | Cadherin_C_2 | 1.06e-04 | 42 | 211 | 5 | PF16492 | |
| Domain | EGF_Ca-bd_CS | 1.16e-04 | 97 | 211 | 7 | IPR018097 | |
| Domain | TSPN | 1.18e-04 | 23 | 211 | 4 | SM00210 | |
| Domain | EGF-like_dom | LAMA1 NPNT VLDLR FAT4 FAT3 THBS2 THBS3 CELSR2 LRP4 LTBP2 OTOG | 1.29e-04 | 249 | 211 | 11 | IPR000742 |
| Domain | EGF_CA | 1.31e-04 | 99 | 211 | 7 | PS01187 | |
| Domain | LamG | 1.33e-04 | 44 | 211 | 5 | SM00282 | |
| Domain | ASX_HYDROXYL | 1.40e-04 | 100 | 211 | 7 | PS00010 | |
| Domain | EGF-type_Asp/Asn_hydroxyl_site | 2.01e-04 | 106 | 211 | 7 | IPR000152 | |
| Domain | ABC_A | 2.90e-04 | 12 | 211 | 3 | IPR026082 | |
| Domain | EGF | 3.52e-04 | 235 | 211 | 10 | SM00181 | |
| Domain | EGF_3 | 3.52e-04 | 235 | 211 | 10 | PS50026 | |
| Domain | UBX_dom | 3.74e-04 | 13 | 211 | 3 | IPR001012 | |
| Domain | UBX | 3.74e-04 | 13 | 211 | 3 | PF00789 | |
| Domain | UBX | 3.74e-04 | 13 | 211 | 3 | PS50033 | |
| Domain | Growth_fac_rcpt_ | 4.04e-04 | 156 | 211 | 8 | IPR009030 | |
| Domain | C1_1 | 4.56e-04 | 57 | 211 | 5 | PF00130 | |
| Domain | EGF_1 | 6.67e-04 | 255 | 211 | 10 | PS00022 | |
| Domain | PROTEIN_KINASE_ATP | ABL1 CDK12 STK35 STK32A AKT1 MAP3K15 TSSK3 RAF1 AMHR2 ADCK2 PIM3 DCLK3 TNK2 PRKCG | 7.56e-04 | 459 | 211 | 14 | PS00107 |
| Domain | ZF_DAG_PE_1 | 7.79e-04 | 64 | 211 | 5 | PS00479 | |
| Domain | ZF_DAG_PE_2 | 7.79e-04 | 64 | 211 | 5 | PS50081 | |
| Domain | EGF-like_CS | 7.97e-04 | 261 | 211 | 10 | IPR013032 | |
| Domain | LAM_G_DOMAIN | 8.65e-04 | 38 | 211 | 4 | PS50025 | |
| Domain | EGF_2 | 8.95e-04 | 265 | 211 | 10 | PS01186 | |
| Domain | Defensin_propep | 1.24e-03 | 5 | 211 | 2 | PF00879 | |
| Domain | TSP_3 | 1.24e-03 | 5 | 211 | 2 | PF02412 | |
| Domain | Alpha-defensin | 1.24e-03 | 5 | 211 | 2 | IPR006081 | |
| Domain | TSP3 | 1.24e-03 | 5 | 211 | 2 | PS51234 | |
| Domain | TSP_CTER | 1.24e-03 | 5 | 211 | 2 | PS51236 | |
| Domain | Alpha-defensin_pro | 1.24e-03 | 5 | 211 | 2 | IPR016327 | |
| Domain | Thrombospondin_3_rpt | 1.24e-03 | 5 | 211 | 2 | IPR017897 | |
| Domain | DEFENSIN | 1.24e-03 | 5 | 211 | 2 | PS00269 | |
| Domain | Defensin_propep | 1.24e-03 | 5 | 211 | 2 | IPR002366 | |
| Domain | TSP_type-3_rpt | 1.24e-03 | 5 | 211 | 2 | IPR028974 | |
| Domain | Defensin_1 | 1.24e-03 | 5 | 211 | 2 | PF00323 | |
| Domain | - | 1.24e-03 | 5 | 211 | 2 | 4.10.1080.10 | |
| Domain | Thrombospondin_C | 1.24e-03 | 5 | 211 | 2 | IPR008859 | |
| Domain | TSP_C | 1.24e-03 | 5 | 211 | 2 | PF05735 | |
| Domain | Thrombospondin_3-like_rpt | 1.24e-03 | 5 | 211 | 2 | IPR003367 | |
| Domain | Protein_kinase_ATP_BS | ABL1 CDK12 STK35 STK32A AKT1 MAP3K15 TSSK3 RAF1 PIM3 DCLK3 TNK2 PRKCG | 1.31e-03 | 379 | 211 | 12 | IPR017441 |
| Domain | Kinase-like_dom | ABL1 CDK12 STK35 STK32A AKT1 MAP3K15 TSSK3 RAF1 AMHR2 ADCK2 PIM3 DCLK3 KNDC1 TNK2 PRKCG | 1.32e-03 | 542 | 211 | 15 | IPR011009 |
| Domain | PROTEIN_KINASE_DOM | ABL1 CDK12 STK35 STK32A AKT1 MAP3K15 TSSK3 RAF1 AMHR2 ADCK2 PIM3 DCLK3 TNK2 PRKCG | 1.49e-03 | 493 | 211 | 14 | PS50011 |
| Domain | PDEase_I | 1.63e-03 | 21 | 211 | 3 | PF00233 | |
| Domain | PDEASE_I | 1.63e-03 | 21 | 211 | 3 | PS00126 | |
| Domain | PDEase_CS | 1.63e-03 | 21 | 211 | 3 | IPR023174 | |
| Domain | 6-blade_b-propeller_TolB-like | 1.78e-03 | 46 | 211 | 4 | IPR011042 | |
| Domain | EPHD | 1.87e-03 | 22 | 211 | 3 | PS51805 | |
| Domain | - | 1.87e-03 | 22 | 211 | 3 | 1.10.1300.10 | |
| Domain | - | ABCA2 ABCA4 ABCA13 MCM5 RAD54L2 MDN1 ATAD2B TJP2 NLRC5 HELZ DNAH6 DNAH2 CHST1 DNAH7 DHX30 DNAH1 GTPBP8 YME1L1 | 2.07e-03 | 746 | 211 | 18 | 3.40.50.300 |
| Domain | PDEase_catalytic_dom | 2.13e-03 | 23 | 211 | 3 | IPR002073 | |
| Domain | HD/PDEase_dom | 2.41e-03 | 24 | 211 | 3 | IPR003607 | |
| Domain | HDc | 2.41e-03 | 24 | 211 | 3 | SM00471 | |
| Domain | Ser/Thr_kinase_AS | CDK12 STK35 STK32A AKT1 MAP3K15 TSSK3 RAF1 AMHR2 PIM3 DCLK3 PRKCG | 2.54e-03 | 357 | 211 | 11 | IPR008271 |
| Domain | PROTEIN_KINASE_ST | CDK12 STK35 STK32A AKT1 MAP3K15 TSSK3 RAF1 AMHR2 PIM3 DCLK3 PRKCG | 2.83e-03 | 362 | 211 | 11 | PS00108 |
| Pathway | KEGG_MEDICUS_VARIANT_MUTATION_CAUSED_ABERRANT_SOD1_TO_RETROGRADE_AXONAL_TRANSPORT | 5.68e-06 | 27 | 138 | 5 | M47755 | |
| Pathway | BIOCARTA_LIS1_PATHWAY | 3.04e-05 | 19 | 138 | 4 | M22005 | |
| Pathway | KEGG_MEDICUS_REFERENCE_RETROGRADE_AXONAL_TRANSPORT | 5.97e-05 | 43 | 138 | 5 | M47669 | |
| Pathway | KEGG_MEDICUS_VARIANT_MUTATION_CAUSED_ABERRANT_HTT_TO_RETROGRADE_AXONAL_TRANSPORT | 7.46e-05 | 45 | 138 | 5 | M47670 | |
| Pubmed | A dual-activity topoisomerase complex regulates mRNA translation and turnover. | ABCA2 ABL1 MAN2A2 MYO9B CDK12 MCM5 ANKLE1 JADE1 KLF4 ZZEF1 PLXNB2 PLEKHG1 ZGPAT KMT2C MDN1 EIF4ENIF1 USP7 NLRC5 AKT1 HECTD1 UNC13B TEAD2 AKNA HUWE1 DENND1A C2CD2 DHX30 PIM3 VAC14 POMGNT2 DNAJC14 CELSR2 ZNF500 LRP4 TNK2 | 1.78e-15 | 1105 | 214 | 35 | 35748872 |
| Pubmed | PCDH11X PCDHB1 PCDHGB6 PCDHAC2 PCDHA10 PCDHA7 PCDHA6 PCDHA4 PCDHA2 PCDHA1 CELSR2 PCDHGB4 | 5.59e-14 | 77 | 214 | 12 | 10835267 | |
| Pubmed | Large exons encoding multiple ectodomains are a characteristic feature of protocadherin genes. | PCDH11X PCDHB1 PCDHGB6 PCDHAC2 PCDHA10 PCDHA7 PCDHA6 PCDHA4 PCDHA2 PCDHA1 CELSR2 PCDHGB4 | 9.01e-14 | 80 | 214 | 12 | 10716726 |
| Pubmed | A striking organization of a large family of human neural cadherin-like cell adhesion genes. | PCDHB1 PCDHGB6 PCDHAC2 PCDHA10 PCDHA7 PCDHA6 PCDHA4 PCDHA2 PCDHA1 CELSR2 PCDHGB4 | 8.04e-13 | 72 | 214 | 11 | 10380929 |
| Pubmed | Cadherin superfamily genes: functions, genomic organization, and neurologic diversity. | PCDH11X PCDHB1 PCDHGB6 PCDHAC2 PCDHA10 PCDHA7 PCDHA6 PCDHA4 PCDHA2 PCDHA1 PCDHGB4 | 1.10e-12 | 74 | 214 | 11 | 10817752 |
| Pubmed | 1.87e-12 | 15 | 214 | 7 | 15640798 | ||
| Pubmed | 5.59e-12 | 17 | 214 | 7 | 29911975 | ||
| Pubmed | CNR/Pcdhalpha family in subplate neurons, and developing cortical connectivity. | 9.09e-12 | 18 | 214 | 7 | 15570159 | |
| Pubmed | Genomic organization of the family of CNR cadherin genes in mice and humans. | 9.09e-12 | 18 | 214 | 7 | 10662547 | |
| Pubmed | Comparative DNA sequence analysis of mouse and human protocadherin gene clusters. | PCDHB1 PCDHGB6 PCDHAC2 PCDHA10 PCDHA7 PCDHA6 PCDHA4 PCDHA2 PCDHA1 PCDHGB4 | 1.34e-11 | 68 | 214 | 10 | 11230163 |
| Pubmed | Clustered gamma-protocadherins regulate cortical interneuron programmed cell death. | PCDHB1 PCDHAC2 PCDHA10 PCDHA7 PCDHA6 PCDHA4 PCDHA2 PCDHA1 PCDHGB4 | 7.44e-11 | 57 | 214 | 9 | 32633719 |
| Pubmed | CTCF Governs the Identity and Migration of MGE-Derived Cortical Interneurons. | PCDHB1 PCDHAC2 PCDHA10 PCDHA7 PCDHA6 PCDHA4 PCDHA2 PCDHA1 PCDHGB4 | 8.76e-11 | 58 | 214 | 9 | 30377227 |
| Pubmed | 9.58e-11 | 24 | 214 | 7 | 24698270 | ||
| Pubmed | Interaction with protocadherin-gamma regulates the cell surface expression of protocadherin-alpha. | 3.21e-10 | 28 | 214 | 7 | 15347688 | |
| Pubmed | A Genome-Wide CRISPR Screen Identifies Genes Critical for Resistance to FLT3 Inhibitor AC220. | PCDH11X NPNT PCDHAC2 PCDHA10 PCDHA7 PCDHA6 PCDHA4 PCDHA2 PCDHA1 | 5.76e-08 | 119 | 214 | 9 | 28625976 |
| Pubmed | The DNA sequence and comparative analysis of human chromosome 5. | 4.21e-07 | 75 | 214 | 7 | 15372022 | |
| Pubmed | Diversity revealed by a novel family of cadherins expressed in neurons at a synaptic complex. | 4.45e-07 | 11 | 214 | 4 | 9655502 | |
| Pubmed | 9.15e-07 | 4 | 214 | 3 | 26365382 | ||
| Pubmed | ABCA2 CDK12 JADE1 ZZEF1 NUP205 KMT2C UBXN4 AP5Z1 SMCHD1 VPS50 AKNA CWC22 WDR19 LRP4 OGA | 1.16e-06 | 529 | 214 | 15 | 14621295 | |
| Pubmed | 1.33e-06 | 14 | 214 | 4 | 9373155 | ||
| Pubmed | ZHX3 TRAF2 JADE1 RAD54L2 MOAP1 EIF4ENIF1 SACS USP7 SECISBP2 RAD23A FAT4 TEX11 TRIM27 HSFX1 DMRTB1 PRKCG | 1.34e-06 | 608 | 214 | 16 | 16713569 | |
| Pubmed | A central chaperone-like role for 14-3-3 proteins in human cells. | PDE3B SRSF10 ABL1 SHKBP1 PLEKHG1 MDN1 NFATC3 TJP2 HELZ BRD1 HECTD1 UTRN PML RAF1 DIP2B DENND1A DNAH7 PRKCG OTOG | 1.85e-06 | 861 | 214 | 19 | 36931259 |
| Pubmed | 2.28e-06 | 5 | 214 | 3 | 39056782 | ||
| Pubmed | BACH2 CEP120 PCDHAC2 PCDHA10 PCDHA7 PCDHA6 PCDHA4 PCDHA2 PCDHA1 | 3.41e-06 | 193 | 214 | 9 | 22589738 | |
| Pubmed | The role of USP7 in the Shoc2-ERK1/2 signaling axis and Noonan-like syndrome with loose anagen hair. | 4.53e-06 | 6 | 214 | 3 | 34553755 | |
| Pubmed | 6.25e-06 | 20 | 214 | 4 | 20711475 | ||
| Pubmed | SRSF10 CDK12 DNAJC21 MCM5 KLF4 INO80D SHKBP1 ZGPAT KMT2C UBXN4 MDN1 EIF4ENIF1 USP7 HELZ UTRN POLR1A TRIM27 DENND1A LRCH3 DHX30 PCF11 MTFR1 LRCH4 CTNNA2 YME1L1 | 6.36e-06 | 1497 | 214 | 25 | 31527615 | |
| Pubmed | ABL1 PEX13 OPTC VPS13A PCDHA10 PCDHA7 PCDHA6 PCDHA2 PCDHA1 CELSR2 LTBP2 | 6.96e-06 | 329 | 214 | 11 | 17474147 | |
| Pubmed | Large-scale characterization of HeLa cell nuclear phosphoproteins. | ZHX3 SRSF10 PDE4C CDK12 TBC1D2 PI4K2A MDN1 EIF2B5 USP7 TJP2 HELZ DIP2B HUWE1 SIRT1 PCF11 OGA TP53BP1 | 6.98e-06 | 774 | 214 | 17 | 15302935 |
| Pubmed | 7.90e-06 | 7 | 214 | 3 | 16059920 | ||
| Pubmed | 9.35e-06 | 22 | 214 | 4 | 24733831 | ||
| Pubmed | E3 ubiquitin ligase RNF123 targets lamin B1 and lamin-binding proteins. | PDE3B LAMA1 TBC1D2 ITGAE ZZEF1 NUP205 KMT2C FREM2 MDN1 ATAD2B VPS13A UTRN FAT4 DNAH2 HUWE1 LONRF2 | 1.48e-05 | 736 | 214 | 16 | 29676528 |
| Pubmed | TRAF2 ABCA2 USP25 RAD54L2 MOAP1 PTPRA SACS USP7 HECTD1 UTRN SMYD3 UNC13B VLDLR HUWE1 DHX30 FAN1 WDR19 DNAJC14 LGI3 LRP4 DAAM2 YME1L1 | 1.62e-05 | 1285 | 214 | 22 | 35914814 | |
| Pubmed | Widespread Expansion of Protein Interaction Capabilities by Alternative Splicing. | TRAF2 SRSF10 RBM12B ANKMY1 ZGPAT AKT1 RAF1 SLC39A4 TEX11 TYMP TRIM27 VAC14 ARSA GRAMD2B DMRTB1 DCTN4 | 1.64e-05 | 742 | 214 | 16 | 26871637 |
| Pubmed | 1.88e-05 | 9 | 214 | 3 | 12154121 | ||
| Pubmed | 1.88e-05 | 9 | 214 | 3 | 28973533 | ||
| Pubmed | TRAF2 ZZEF1 MDN1 FAF2 VPS13A HECTD1 UTRN ADCK2 SIRT1 MTFR1 GSTCD YME1L1 VPS53 | 2.08e-05 | 515 | 214 | 13 | 31617661 | |
| Pubmed | TRIML1 TRAF2 BACH2 ZZEF1 INO80D EIF4ENIF1 USP7 HELZ BRD1 PML RAF1 VLDLR FAT3 VPS50 TRIM27 SIRT1 ACTR6 LRP4 YME1L1 VPS53 | 2.11e-05 | 1116 | 214 | 20 | 31753913 | |
| Pubmed | 2.19e-05 | 27 | 214 | 4 | 11156964 | ||
| Pubmed | SHKBP1 PLEKHG1 EIF4ENIF1 TJP2 HELZ HECTD1 UTRN RAF1 TRIM27 DENND1A LRCH3 LRCH4 | 2.34e-05 | 446 | 214 | 12 | 24255178 | |
| Pubmed | Regulation of WASH-dependent actin polymerization and protein trafficking by ubiquitination. | 2.67e-05 | 10 | 214 | 3 | 23452853 | |
| Pubmed | Epigenetic functions of smchd1 repress gene clusters on the inactive X chromosome and on autosomes. | 3.22e-05 | 59 | 214 | 5 | 23754746 | |
| Pubmed | Neutrophil defensins enhance lung epithelial wound closure and mucin gene expression in vitro. | 3.77e-05 | 2 | 214 | 2 | 12871849 | |
| Pubmed | Ack1 mediated AKT/PKB tyrosine 176 phosphorylation regulates its activation. | 3.77e-05 | 2 | 214 | 2 | 20333297 | |
| Pubmed | Raf-1, actin dynamics, and abelson tyrosine kinase in human airway smooth muscle cells. | 3.77e-05 | 2 | 214 | 2 | 23087049 | |
| Pubmed | SMYD3-mediated lysine methylation in the PH domain is critical for activation of AKT1. | 3.77e-05 | 2 | 214 | 2 | 27626683 | |
| Pubmed | 3.77e-05 | 2 | 214 | 2 | 19147802 | ||
| Pubmed | The uncommon occurrence of two common inherited disorders in a single patient: a mini case series. | 3.77e-05 | 2 | 214 | 2 | 30156925 | |
| Pubmed | 3.77e-05 | 2 | 214 | 2 | 18550470 | ||
| Pubmed | Relative abundance of thrombospondin 2 and thrombospondin 3 mRNAs in human tissues. | 3.77e-05 | 2 | 214 | 2 | 10329465 | |
| Pubmed | 3.77e-05 | 2 | 214 | 2 | 21333105 | ||
| Pubmed | Midpregnancy vaginal fluid defensins, bacterial vaginosis, and risk of preterm delivery. | 3.77e-05 | 2 | 214 | 2 | 18757648 | |
| Pubmed | 3.77e-05 | 2 | 214 | 2 | 16837860 | ||
| Pubmed | 3.77e-05 | 2 | 214 | 2 | 21881167 | ||
| Pubmed | Acidic glycosaminoglycans and laminin-1 in renal corpuscles of mutant blebs (my) and control mice. | 3.77e-05 | 2 | 214 | 2 | 9302549 | |
| Pubmed | 3.77e-05 | 2 | 214 | 2 | 25389299 | ||
| Pubmed | 3.77e-05 | 2 | 214 | 2 | 18686341 | ||
| Pubmed | 3.77e-05 | 2 | 214 | 2 | 20880148 | ||
| Pubmed | 3.77e-05 | 2 | 214 | 2 | 28677744 | ||
| Pubmed | 3.77e-05 | 2 | 214 | 2 | 26633713 | ||
| Pubmed | 3.77e-05 | 2 | 214 | 2 | 20424487 | ||
| Pubmed | Detection of colorectal disease by stool defensin assay: an exploratory study. | 3.77e-05 | 2 | 214 | 2 | 17531545 | |
| Pubmed | 3.77e-05 | 2 | 214 | 2 | 18182859 | ||
| Pubmed | USP7 regulates the ERK1/2 signaling pathway through deubiquitinating Raf-1 in lung adenocarcinoma. | 3.77e-05 | 2 | 214 | 2 | 35948545 | |
| Pubmed | 3.77e-05 | 2 | 214 | 2 | 24330068 | ||
| Pubmed | 3.77e-05 | 2 | 214 | 2 | 23357418 | ||
| Pubmed | Crystal structure of defensin HNP-3, an amphiphilic dimer: mechanisms of membrane permeabilization. | 3.77e-05 | 2 | 214 | 2 | 2006422 | |
| Pubmed | Antibodies against low-density lipoprotein receptor-related protein 4 induce myasthenia gravis. | 3.77e-05 | 2 | 214 | 2 | 24200689 | |
| Pubmed | 3.77e-05 | 2 | 214 | 2 | 25982963 | ||
| Pubmed | 3.77e-05 | 2 | 214 | 2 | 24317448 | ||
| Pubmed | Increased levels of alpha-defensin (-1, -2 and -3) in type 1 diabetic patients with nephropathy. | 3.77e-05 | 2 | 214 | 2 | 18003664 | |
| Pubmed | 3.77e-05 | 2 | 214 | 2 | 22297599 | ||
| Pubmed | USP7 promotes IgA class switching through stabilizing RUNX3 for germline transcription activation. | 3.77e-05 | 2 | 214 | 2 | 38735043 | |
| Pubmed | Human Neutrophil Peptides 1-3--early markers in development of colorectal adenomas and carcinomas. | 3.77e-05 | 2 | 214 | 2 | 18957723 | |
| Pubmed | 3.77e-05 | 2 | 214 | 2 | 21305000 | ||
| Pubmed | Salivary levels of HNP 1-3 are related to oral ulcer activity in Behçet's disease. | 3.77e-05 | 2 | 214 | 2 | 22861387 | |
| Pubmed | 3.77e-05 | 2 | 214 | 2 | 36882837 | ||
| Pubmed | Defensins: antimicrobial and cytotoxic peptides of mammalian cells. | 3.77e-05 | 2 | 214 | 2 | 8476558 | |
| Pubmed | 3.77e-05 | 2 | 214 | 2 | 18986978 | ||
| Pubmed | Corneal stromal cells (keratocytes) express thrombospondins 2 and 3 in wound repair phenotype. | 3.77e-05 | 2 | 214 | 2 | 11943589 | |
| Pubmed | Nerve growth factor upregulates sirtuin 1 expression in cholestasis: a potential therapeutic target. | 3.77e-05 | 2 | 214 | 2 | 29328070 | |
| Pubmed | Localization of human neutrophil peptide (HNP) and its messenger RNA in neutrophil series. | 3.77e-05 | 2 | 214 | 2 | 8080882 | |
| Pubmed | Distinct roles of muscle and motoneuron LRP4 in neuromuscular junction formation. | 3.77e-05 | 2 | 214 | 2 | 22794264 | |
| Pubmed | 3.77e-05 | 2 | 214 | 2 | 16046028 | ||
| Pubmed | 3.77e-05 | 2 | 214 | 2 | 19864642 | ||
| Pubmed | 3.77e-05 | 2 | 214 | 2 | 25294876 | ||
| Pubmed | Giant cadherins Fat and Dachsous self-bend to organize properly spaced intercellular junctions. | 3.77e-05 | 2 | 214 | 2 | 25355906 | |
| Pubmed | 3.77e-05 | 2 | 214 | 2 | 30954556 | ||
| Pubmed | 3.77e-05 | 2 | 214 | 2 | 22231444 | ||
| Pubmed | Alpha-defensin overexpression in patients with Bell's palsy and Ramsay Hunt syndrome. | 3.77e-05 | 2 | 214 | 2 | 22737966 | |
| Pubmed | 3.77e-05 | 2 | 214 | 2 | 23892093 | ||
| Pubmed | 3.77e-05 | 2 | 214 | 2 | 7968380 | ||
| Pubmed | 3.77e-05 | 2 | 214 | 2 | 15208269 | ||
| Pubmed | Plasma human neutrophil proteins-1, -2, and -3 levels in patients with bladder cancer. | 3.77e-05 | 2 | 214 | 2 | 23011762 | |
| Pubmed | 3.77e-05 | 2 | 214 | 2 | 20195543 | ||
| Pubmed | The deacetylation of Akt by SIRT1 inhibits inflammation in macrophages and protects against sepsis. | 3.77e-05 | 2 | 214 | 2 | 37211747 | |
| Pubmed | 3.77e-05 | 2 | 214 | 2 | 34399163 | ||
| Pubmed | 3.77e-05 | 2 | 214 | 2 | 29950924 | ||
| Pubmed | Increased levels of human neutrophil alpha-defensins in chronic venous leg ulcers. | 3.77e-05 | 2 | 214 | 2 | 18472248 | |
| Pubmed | Structure of the planar cell polarity cadherins Fat4 and Dachsous1. | 3.77e-05 | 2 | 214 | 2 | 36797229 | |
| Interaction | ZBBX interactions | 8.42e-10 | 31 | 212 | 8 | int:ZBBX | |
| Interaction | TOP3B interactions | ABCA2 ABL1 MAN2A2 MYO9B CDK12 MCM5 ANKLE1 JADE1 KLF4 ZZEF1 PLXNB2 PLEKHG1 ZGPAT KMT2C MDN1 EIF4ENIF1 USP7 NLRC5 SECISBP2 HELZ AKT1 HECTD1 UNC13B TEAD2 AKNA HUWE1 DENND1A C2CD2 DHX30 PIM3 VAC14 POMGNT2 DNAJC14 CELSR2 ZNF500 LRP4 TNK2 DCTN4 OGA TP53BP1 | 2.35e-08 | 1470 | 212 | 40 | int:TOP3B |
| Interaction | DCANP1 interactions | 3.06e-08 | 19 | 212 | 6 | int:DCANP1 | |
| Interaction | PCDHA8 interactions | 1.05e-07 | 55 | 212 | 8 | int:PCDHA8 | |
| Interaction | PCDHA10 interactions | 2.80e-06 | 22 | 212 | 5 | int:PCDHA10 | |
| Interaction | XAGE1A interactions | 4.18e-06 | 41 | 212 | 6 | int:XAGE1A | |
| Interaction | NUP210P1 interactions | 4.83e-06 | 42 | 212 | 6 | int:NUP210P1 | |
| Interaction | C2CD4B interactions | 6.39e-06 | 44 | 212 | 6 | int:C2CD4B | |
| Interaction | ADAMTS13 interactions | 6.75e-06 | 26 | 212 | 5 | int:ADAMTS13 | |
| Interaction | RELN interactions | 8.22e-06 | 27 | 212 | 5 | int:RELN | |
| Interaction | PCDHA7 interactions | 1.10e-05 | 14 | 212 | 4 | int:PCDHA7 | |
| Interaction | ERCC3 interactions | 1.70e-05 | 175 | 212 | 10 | int:ERCC3 | |
| Interaction | PCDHA9 interactions | 1.96e-05 | 32 | 212 | 5 | int:PCDHA9 | |
| Interaction | AKAP1 interactions | PEX13 NUP205 OPTC UBXN4 MDN1 FAF2 VPS13A USP7 HELZ HECTD1 RAF1 HUWE1 DHX30 C1orf198 MTFR1 NAA40 YME1L1 | 2.52e-05 | 503 | 212 | 17 | int:AKAP1 |
| Interaction | FLT3 interactions | NUP205 MDN1 PCDH11X NPNT PCDHAC2 PCDHA10 PCDHA7 PCDHA6 PCDHA4 PCDHA2 PCDHA1 HUWE1 DHX30 | 3.42e-05 | 318 | 212 | 13 | int:FLT3 |
| Interaction | PCDHA11 interactions | 4.08e-05 | 19 | 212 | 4 | int:PCDHA11 | |
| Interaction | PDE7A interactions | 7.50e-05 | 22 | 212 | 4 | int:PDE7A | |
| Interaction | LOC254896 interactions | 8.54e-05 | 43 | 212 | 5 | int:LOC254896 | |
| Cytoband | 5q31 | PCDHB1 PCDHGB6 PCDHAC2 PCDHA10 PCDHA7 PCDHA6 PCDHA4 PCDHA2 PCDHA1 PCDHGB4 | 1.91e-10 | 115 | 214 | 10 | 5q31 |
| Cytoband | Ensembl 112 genes in cytogenetic band chr5q31 | PCDHB1 PCDHGB6 PCDHAC2 PCDHA10 PCDHA7 PCDHA6 PCDHA4 PCDHA2 PCDHA1 PCDHGB4 | 1.60e-06 | 298 | 214 | 10 | chr5q31 |
| Cytoband | 22q13.33 | 2.99e-05 | 38 | 214 | 4 | 22q13.33 | |
| GeneFamily | Clustered protocadherins | PCDHB1 PCDHGB6 PCDHAC2 PCDHA10 PCDHA7 PCDHA6 PCDHA4 PCDHA2 PCDHA1 PCDHGB4 | 8.42e-11 | 64 | 145 | 10 | 20 |
| GeneFamily | Dyneins, axonemal | 8.71e-06 | 17 | 145 | 4 | 536 | |
| GeneFamily | UBX domain containing | 1.36e-04 | 13 | 145 | 3 | 364 | |
| GeneFamily | ATP binding cassette subfamily A | 1.72e-04 | 14 | 145 | 3 | 805 | |
| GeneFamily | Cadherin related | 3.16e-04 | 17 | 145 | 3 | 24 | |
| GeneFamily | Phosphodiesterases | 9.04e-04 | 24 | 145 | 3 | 681 | |
| Coexpression | BUSSLINGER_GASTRIC_IMMUNE_CELLS | SRSF10 MAN2A2 TNFSF12 MYO9B USP25 JADE1 ITGAE INO80D TBC1D20 PIK3IP1 KMT2C UBXN4 PTPRA STYX SACS NFATC3 C19orf12 TRPV2 NLRC5 SECISBP2 HELZ UTRN SMCHD1 AKNA HUWE1 RUNX3 PCF11 OXNAD1 TNK2 OGA YME1L1 RASGRP2 | 4.97e-07 | 1492 | 213 | 32 | M40023 |
| Coexpression | MIKKELSEN_MEF_HCP_WITH_H3_UNMETHYLATED | FAM178B B3GNT8 PCDHB1 PCDHA10 PCDHA7 PCDHA6 PCDHA4 PCDHA2 PCDHA1 TEX11 LGI3 | 4.34e-06 | 238 | 213 | 11 | M2020 |
| Coexpression | MIKKELSEN_MEF_HCP_WITH_H3_UNMETHYLATED | FAM178B B3GNT8 PCDHB1 PCDHA10 PCDHA7 PCDHA6 PCDHA4 PCDHA2 PCDHA1 TEX11 LGI3 | 1.04e-05 | 261 | 213 | 11 | MM1277 |
| Coexpression | THAKAR_PBMC_INACTIVATED_INFLUENZA_AGE_21_30YO_RESPONDERS_28DY_DN | PDE4C ABL1 MAN2A2 TNFSF12 MYO9B TBC1D2 ANKMY1 RAD54L2 ZZEF1 PLXNB2 IRF9 NLRC5 KATNIP AKT1 UTRN RAF1 RUNX3 DNAH1 UBXN11 LRCH4 TNK2 | 1.70e-05 | 905 | 213 | 21 | M40865 |
| Coexpression | EIF4E_DN | 1.79e-05 | 100 | 213 | 7 | M2790 | |
| Coexpression | THAKAR_PBMC_INACTIVATED_INFLUENZA_AGE_21_30YO_RESPONDERS_7DY_DN | PDE4C TNFSF12 TBC1D2 ANKMY1 RAD54L2 ZZEF1 PLXNB2 IRF9 NLRC5 KATNIP AKT1 RAF1 LRCH3 DNAH1 UBXN11 LRCH4 TNK2 | 1.86e-05 | 634 | 213 | 17 | M40866 |
| Coexpression | DACOSTA_UV_RESPONSE_VIA_ERCC3_DN | ZHX3 MYO9B ZZEF1 PTPRA MDN1 SACS NFATC3 ATAD2B VPS13A USP7 TJP2 HELZ VLDLR SMCHD1 C2CD2 PCF11 THBS2 MTFR1 IL1RAP TP53BP1 | 2.47e-05 | 856 | 213 | 20 | M4500 |
| Coexpression | GSE14699_NAIVE_VS_DELETIONAL_TOLERANCE_CD8_TCELL_DN | 4.02e-05 | 200 | 213 | 9 | M2936 | |
| CoexpressionAtlas | DevelopingGonad_e16.5_ovary_emap-9563_k-means-cluster#5_top-relative-expression-ranked_1000 | TKTL1 PDE10A DMXL1 PIK3IP1 KMT2C SEMA6D SACS AMHR2 DNAH7 THBS2 ACTR6 LONRF2 | 1.80e-06 | 219 | 208 | 12 | gudmap_developingGonad_e16.5_ovary_1000_k5 |
| CoexpressionAtlas | DevelopingGonad_e18.5_ovary_emap-12283_k-means-cluster#5_top-relative-expression-ranked_1000 | DNAJC21 TKTL1 DMXL1 KMT2C SACS AMHR2 ENPP4 DNAH7 THBS2 ACTR6 MTFR1 LONRF2 | 3.00e-06 | 230 | 208 | 12 | gudmap_developingGonad_e18.5_ovary_1000_k5 |
| CoexpressionAtlas | dev gonad_e13.5_F_MeioticGermCell_Oct_top-relative-expression-ranked_1000 | TTC39B PDE3B CDK12 DNAJC21 MCM5 TKTL1 SPA17 STK35 DMXL1 KMT2C MDN1 VPS13A HELZ MAP3K15 NPNT UNC13B VPS50 ENPP4 HUWE1 TEX11 SIRT1 RBPMS2 LONRF2 | 6.07e-06 | 820 | 208 | 23 | gudmap_dev gonad_e13.5_F_MeioticGermCell_Oct_1000 |
| CoexpressionAtlas | gamma delta T cells, Tgd.vg2+.act.Sp, TCRd+ Vg2+ CD44+, Spleen, avg-3 | TTC39B PDE3B ABCA2 ACP3 ITGAE PIK3IP1 ZGPAT NFATC3 NLRC5 UTRN AKNA RUNX3 GRAMD2B TNK2 RASGRP2 | 8.79e-06 | 395 | 208 | 15 | GSM476678_500 |
| CoexpressionAtlas | alpha beta T cells, T.8Nve.PP, TCRb+ CD8+ CD44low CD62L high, Peyer's Patch, avg-1 | PDE3B BACH2 ACP3 ITGAE PIK3IP1 ZGPAT KMT2C MDN1 VPS13A NLRC5 UTRN RUNX3 GRAMD2B | 2.91e-05 | 336 | 208 | 13 | GSM538413_500 |
| CoexpressionAtlas | alpha beta T cells, T.8Nve.PP, TCR+ CD8+ CD44low CD62Lhigh, Peyer's Patch, avg-1 | PDE3B BACH2 ITGAE PIK3IP1 ZGPAT MDN1 VPS13A NLRC5 KATNIP UTRN RUNX3 GRAMD2B | 7.29e-05 | 317 | 208 | 12 | GSM538412_500 |
| CoexpressionAtlas | DevelopingGonad_P2_ovary_emap-30224_k-means-cluster#3_top-relative-expression-ranked_100 | 1.06e-04 | 10 | 208 | 3 | gudmap_developingGonad_P2_ovary_100_k3 | |
| CoexpressionAtlas | gamma delta T cells, Tgd.vg2-.Sp, TCRd+ Vg2- CD44-, Spleen, avg-3 | PDE3B ABCA2 BACH2 ITGAE PIK3IP1 ZGPAT NFATC3 NLRC5 UTRN AKNA RUNX3 GRAMD2B RASGRP2 | 1.07e-04 | 382 | 208 | 13 | GSM476684_500 |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-thymocyte|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.23e-08 | 184 | 214 | 10 | 2cbed6462fea2622871bb7e49b0df3d984239281 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-proliferating_thymocyte;_DN_to_DP_transition,_dividing_(some_are_Cd8+/_Cd4+,_some_undergoing_VDJ_recombination)|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.23e-08 | 184 | 214 | 10 | 2b19a8c5f823e00812908b23e66bb4e563278aff | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.23e-08 | 184 | 214 | 10 | ea7a7e2bac46d4d2c31a5d576b38a032b5335062 | |
| ToppCell | mild-low-quality_cells|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | TTC39B PDE3B SRSF10 IRF9 ATAD2B VPS13A NLRC5 UTRN SMCHD1 AKNA | 4.69e-08 | 199 | 214 | 10 | f0b0097df0026496470a80d8cc9375ffd8389b00 |
| ToppCell | TCGA-Ovary-Primary_Tumor-Ovarian_Carcinoma-Serous_Cystadenocarcinoma-5|TCGA-Ovary / Sample_Type by Project: Shred V9 | 1.17e-07 | 166 | 214 | 9 | 32d2eaf8a5d03881bf74d680825af2d5110b082d | |
| ToppCell | droplet-Marrow-nan-18m-Myeloid-basophil|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.07e-06 | 174 | 214 | 8 | 55cc8300489d11322724159ec7d0e1d32a702e91 | |
| ToppCell | 5'-Parenchyma_lung-Mesenchymal-Mesenchymal_Myocytic-myocytic_fibroblast-Myofibroblasts-Myofibroblasts_L.2.3.2.2|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.78e-06 | 181 | 214 | 8 | b116c68393d8836bac080f81a8fcbeb52e0403e7 | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Immune-Lymphocytic_T/NK|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 3.40e-06 | 186 | 214 | 8 | 9d576dce2c5deefef1adda16c6da7055c8d57f8f | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Immune-Lymphocytic_T/NK-T_Cell-|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 3.40e-06 | 186 | 214 | 8 | bd3bd022b575d9b0ef90d50a5cb874085a827b77 | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Immune-Lymphocytic_T/NK-T_Cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 3.40e-06 | 186 | 214 | 8 | 924cc357b4c4ce8e9b05773bdab544f0b65474cc | |
| ToppCell | Fetal_29-31_weeks-Immune-T_lymphocyte-D062|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 4.29e-06 | 192 | 214 | 8 | 92f141d5ac462f652f405efa73ac6ef751f40ea3 | |
| ToppCell | COPD-Lymphoid|COPD / Disease state, Lineage and Cell class | 4.29e-06 | 192 | 214 | 8 | 064fefb8212fadab0ff441f4bf643559b7fdb25d | |
| ToppCell | Fetal_29-31_weeks-Immune-T_lymphocyte|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 4.29e-06 | 192 | 214 | 8 | 69a2b04f03a1b82d067018379f7b8a116e954040 | |
| ToppCell | severe-low-quality_cells|severe / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 4.46e-06 | 193 | 214 | 8 | 9337bc93e3904c7fc7c93c328518bcd6453b1e8c | |
| ToppCell | 390C-Lymphocytic-ILC-ILC-1|ILC / Donor, Lineage, Cell class and subclass (all cells) | 4.57e-06 | 51 | 214 | 5 | f97523d1cae5932d9a4e8d7f37c202b12e5a0685 | |
| ToppCell | droplet-Limb_Muscle-MUSCLE-1m-Mesenchymal-smooth_muscle_cell|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.63e-06 | 194 | 214 | 8 | b8a130ffae68ffe550bf335460a1ec1035cf8d8d | |
| ToppCell | Children_(3_yrs)-Immune-T_lymphocyte-D139|Children_(3_yrs) / Lineage, Cell type, age group and donor | 4.63e-06 | 194 | 214 | 8 | 3d6f2d190dd50804afea299957cc44c2bb756134 | |
| ToppCell | severe-low-quality_cells|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 5.19e-06 | 197 | 214 | 8 | 57ebd552f10d6278623b52a3d484d4b91ae1d028 | |
| ToppCell | COVID-19_Mild|World / Disease group, lineage and cell class | 5.19e-06 | 197 | 214 | 8 | 5c33454b10023decd2f5ccda9229b6512659711e | |
| ToppCell | PBMC-Mild|PBMC / Location, Disease Group, Cell group, Cell class (2021.03.09) | 5.38e-06 | 198 | 214 | 8 | 44417089b62056269cac38d3134ff209c05b7007 | |
| ToppCell | PBMC-Mild|PBMC / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 5.38e-06 | 198 | 214 | 8 | 28ef3fc4c17dcb765537b75917f7db78baa522db | |
| ToppCell | (03)_KRT6B+-(2)_GFP_FOXI1|(03)_KRT6B+ / shred by cell type by condition | 5.59e-06 | 199 | 214 | 8 | c425e7975f492ed5cfcca022248adb627e1d27d4 | |
| ToppCell | Tracheal-NucSeq-Immune_Lymphocytic-T-T_CD8-CD8|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 5.80e-06 | 200 | 214 | 8 | 5f41906cf1585e09b150a84364d47c3e466dc5b7 | |
| ToppCell | COVID-19-COVID-19_Mild|COVID-19 / Disease, condition lineage and cell class | 5.80e-06 | 200 | 214 | 8 | 62c25042086f1afd1102e0720e933c2e476468fd | |
| ToppCell | Parenchymal-NucSeq-Immune_Lymphocytic-T-T_CD4|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 5.80e-06 | 200 | 214 | 8 | f7a9d8b99de19e9842422bada348d940e0863645 | |
| ToppCell | facs-Marrow-T-cells-24m-Lymphocytic-precursor_B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.16e-05 | 158 | 214 | 7 | 8c7108f2c40d97a317762ba0b8eca76542b2ebaf | |
| ToppCell | facs-Marrow-T-cells-24m-Lymphocytic-pre_B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.16e-05 | 158 | 214 | 7 | f296ca24fdedc33f1d24b79e7660763114ce7fa3 | |
| ToppCell | droplet-Lung-nan-3m-Myeloid-Myeloid_Dendritic_Type_2|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.66e-05 | 167 | 214 | 7 | f33cef917fa733adf6d5a9a9e989a4d9fd462a8f | |
| ToppCell | PND07-28-samps-Epithelial-Epithelial-non_alveolar-Ciliated_cell_of_lung_parenchyma|PND07-28-samps / Age Group, Lineage, Cell class and subclass | 2.16e-05 | 174 | 214 | 7 | f41d05a3703d7092bd3c4a97c15ae13069aaa4ad | |
| ToppCell | Children_(3_yrs)-Immune-natural_killer_cell-D032|Children_(3_yrs) / Lineage, Cell type, age group and donor | 2.16e-05 | 174 | 214 | 7 | 33d6b81f31bfcb9c4b30206d88e20b9a94fba4a2 | |
| ToppCell | 10x3'2.3-week_17-19-Lymphocytic_NK|week_17-19 / cell types per 3 fetal stages;per 3',per 5' | 2.69e-05 | 180 | 214 | 7 | 1c8398342d3fa4d5ca9a8a63626cc497c5291446 | |
| ToppCell | 10x3'2.3-week_17-19-Lymphocytic_NK-T_NK|week_17-19 / cell types per 3 fetal stages;per 3',per 5' | 2.69e-05 | 180 | 214 | 7 | 0a98d21fec67a890e75ebf0e2d23adddd77da214 | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Glutamatergic_Excit-Glut_C-D_(RORB)-Glut_D_(IT_RORB_THEMIS_LINC00507)_5-Exc_L4-5_RORB_HNRNPA1P46|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.69e-05 | 180 | 214 | 7 | 8923a42a6db9c6e9f3ce2ca9530e620dfea700ba | |
| ToppCell | PBMC_fresh-frozen-Mild-Moderate_progression_d02_child-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell-T_CD8_c01-LEF1|Mild-Moderate_progression_d02_child / Compartment, severity and other cell annotations on 10x 3' data (130k) | 2.89e-05 | 123 | 214 | 6 | 511b7c20a4a85e49980936d52af7dbca19bb848e | |
| ToppCell | droplet-Lung-nan-21m-Lymphocytic-Ly6g5b+_T|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.99e-05 | 183 | 214 | 7 | 302bd0f1f8025f385a764f2a9adafdd7f1f67ea3 | |
| ToppCell | PBMC-Mild-Myeloid-Neutrophil-immature_Neutrophil-Neu_4|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 3.31e-05 | 126 | 214 | 6 | 69b2525b92d1c7c35b21cc701f5fa52a9c1b94bb | |
| ToppCell | PBMC-Mild-Myeloid-Neutrophil-immature_Neutrophil-Neu_4|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 3.31e-05 | 126 | 214 | 6 | 6cb89754010d64875e115da6c5805efac7a4a82d | |
| ToppCell | PCW_07-8.5-Mesenchymal-Mesenchymal_myocytic-mes_immature_ASM2_(12)|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 3.55e-05 | 188 | 214 | 7 | 3004e961d214919e08c7cd5f10c3de5cf85b35a3 | |
| ToppCell | 10x5'-GI_small-bowel-Lymphocytic_T_CD4-T_CD4/CD8|GI_small-bowel / Manually curated celltypes from each tissue | 3.55e-05 | 188 | 214 | 7 | ab9b725d6e0cdab8e9ddda6dee09e14730e9a578 | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d12-22_with-steroid-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell-T_CD4_c06-NR4A2|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k) | 3.55e-05 | 188 | 214 | 7 | 939790f133eac9c12d08db6ddb5f08f5107844e3 | |
| ToppCell | LPS-antiTNF-Epithelial_alveolar-Mes-Like-Differentiating_AT1|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 3.61e-05 | 128 | 214 | 6 | 2cf0384240a4a663869cf6b27d954236f6214a9a | |
| ToppCell | IPF-Lymphoid-T_Cytotoxic|IPF / Disease state, Lineage and Cell class | 3.79e-05 | 190 | 214 | 7 | e5d0186bfb416a3eda76ac12b9379650afb6f409 | |
| ToppCell | IPF-Lymphoid-T|IPF / Disease state, Lineage and Cell class | 3.79e-05 | 190 | 214 | 7 | d57df208aaf7a5554899bb9107c80b443fd0cf93 | |
| ToppCell | droplet-Heart-HEART-1m-Mesenchymal-smooth_muscle_cell|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.92e-05 | 191 | 214 | 7 | 5c1f5b6c115b1b27b4a7467a6550ce43c01cf6d0 | |
| ToppCell | COPD-Lymphoid-T|World / Disease state, Lineage and Cell class | 4.06e-05 | 192 | 214 | 7 | eb4909574fb5fc91399463523e2737095773200a | |
| ToppCell | IPF-Lymphoid-T|World / Disease state, Lineage and Cell class | 4.06e-05 | 192 | 214 | 7 | b25ba1f3bc842c22602b2aeed3b1b5082863e4fa | |
| ToppCell | COPD-Lymphoid-T_Cytotoxic|World / Disease state, Lineage and Cell class | 4.06e-05 | 192 | 214 | 7 | 5bfd9f5d47511441eb2d3cc3c4d7ed330ffd0bd1 | |
| ToppCell | droplet-Heart-HEART-1m-Mesenchymal-smooth_muscle_cell|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.06e-05 | 192 | 214 | 7 | eb9a0b3d32f90f8b95905c740aab21639dae5cbd | |
| ToppCell | IPF-Lymphoid-T_Cytotoxic|Lymphoid / Disease state, Lineage and Cell class | 4.19e-05 | 193 | 214 | 7 | 3c8a022dbd4f8d25b14fd137ce64c2713a7dbe41 | |
| ToppCell | 5'-Adult-SmallIntestine-Hematopoietic-T_cells-TRGV2_gdT|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 4.19e-05 | 193 | 214 | 7 | 544de0988510cc57744710d7cafe07aa27a0b99d | |
| ToppCell | IPF-Lymphoid-T_Cytotoxic|World / Disease state, Lineage and Cell class | 4.19e-05 | 193 | 214 | 7 | 35c902a983d7f1156a74fe68ee366609029833b3 | |
| ToppCell | (1)_T_cells-(1)_T_CD4_naive|(1)_T_cells / Spleen cell shreds - cell class (v1) and cell subclass (v1) | 4.47e-05 | 195 | 214 | 7 | d3fa551bc6f5ee5890af1040415e61ecd5d46201 | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Myeloid-TAM-BDM-TAM-BDM_hypoxia/MES-E|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 4.47e-05 | 195 | 214 | 7 | d53585715c7f5827c4f5a6db11cb31857ee9d4f0 | |
| ToppCell | droplet-Limb_Muscle-MUSCLE-1m-Mesenchymal-unknown|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.47e-05 | 195 | 214 | 7 | 0bdf845939bc4b8cc94f2808aea60f818425b076 | |
| ToppCell | Fetal_brain-fetalBrain_Zhong_nature-GW08-Neuronal-GABAergic_neurons|GW08 / Sample Type, Dataset, Time_group, and Cell type. | 4.77e-05 | 197 | 214 | 7 | e1a80c1aa7f7e83f5d19a40fe37db5c5a6c25685 | |
| ToppCell | Tracheal-NucSeq-Immune_Lymphocytic-T-T_CD8-gdT|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 4.77e-05 | 197 | 214 | 7 | b803c07072a7860497d07a3be358a28a24359cbf | |
| ToppCell | LPS_only-Epithelial_airway-airway_epithelial-Ciliated|LPS_only / Treatment groups by lineage, cell group, cell type | 4.93e-05 | 198 | 214 | 7 | 6d90b541fde357fbb40f8f7d4e8628a48b679718 | |
| ToppCell | Parenchymal-10x3prime_v2-Stromal-Mesofibroblastic-Mesothelia|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations | 4.93e-05 | 198 | 214 | 7 | e0df6d6ff2a9c41d813f84a2a5ee7cb5f6fc3e30 | |
| ToppCell | 5'-GW_trimst-2-LymphNode-Hematopoietic-T_cells-SELL+_CD8_T|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 4.93e-05 | 198 | 214 | 7 | 0dac00a64fe08ec6669af3ddd4b82413b673233d | |
| ToppCell | Parenchymal-10x3prime_v2-Stromal-Mesofibroblastic|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations | 4.93e-05 | 198 | 214 | 7 | 0cd930e374c2c48d1991b51c025f9801b22ecee7 | |
| ToppCell | LPS_anti-TNF-Epithelial_airway-airway_epithelial-Ciliated|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 5.09e-05 | 199 | 214 | 7 | 15f7814b7074170eee7ccacaa670b1d128fc68bb | |
| ToppCell | Fetal_brain-organoid_Tanaka_cellReport-GW10-Neuronal-Intermediate|GW10 / Sample Type, Dataset, Time_group, and Cell type. | 5.09e-05 | 199 | 214 | 7 | cf592d93612023a13de21e0fb8c6b13714f9af71 | |
| ToppCell | Tracheal-NucSeq|Tracheal / Cell types per location group and 10X technology with lineage, and cell group designations | 5.09e-05 | 199 | 214 | 7 | 94b94b17ca18b8dc27b91da1f2ccf89e03cc7035 | |
| ToppCell | COVID-19-lung|COVID-19 / Disease (COVID-19 only), tissue and cell type | 5.09e-05 | 199 | 214 | 7 | 155b03b859157013e9142e9248551369127d9204 | |
| ToppCell | Bronchial-NucSeq-Immune_Lymphocytic-T-T_CD8-CD8|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 5.25e-05 | 200 | 214 | 7 | 20ffb3436d08042f77800513e6ddb3bbc38ae6fe | |
| ToppCell | mild|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 5.25e-05 | 200 | 214 | 7 | 12f1685ce8f218433068e090c9d839cd5a1910bf | |
| ToppCell | Fetal_brain-organoid_Tanaka_cellReport-GW12-Mesenchymal-Unfolded_protein_responsible_cell|GW12 / Sample Type, Dataset, Time_group, and Cell type. | 5.25e-05 | 200 | 214 | 7 | 6b7314c425f6b40f1301dd39cc02b0436e96a2ec | |
| ToppCell | Parenchymal-NucSeq-Immune_Lymphocytic-T-T_CD8-CD8_TRM|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 5.25e-05 | 200 | 214 | 7 | 9ef322486e46e4ff05a8cbe06cf8019e996c94b3 | |
| ToppCell | Macroglial-Polydendrocytes|Macroglial / cells hierarchy compared to all cells using T-Statistic | 5.25e-05 | 200 | 214 | 7 | 961858738ce35db8760c8c2e136f8369bc444ccf | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Glial-Neuronal-Oligodendrocyte-Oligodendrocyte-F|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 5.25e-05 | 200 | 214 | 7 | 829978708463a7459fe1041bd90196775bc4b531 | |
| ToppCell | LPS_IL1RA-Hematopoietic_Erythro-Megakary-Erythro-Mega-Platelets|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 5.25e-05 | 200 | 214 | 7 | 326cae37cacd94b423a6ac8873ea56c5abaf0a0b | |
| ToppCell | Macroglial-Polydendrocytes-PDGFRA-|Macroglial / cells hierarchy compared to all cells using T-Statistic | 5.25e-05 | 200 | 214 | 7 | f17b5a54e8f9eba9dcd0808ba4e8d275ac41bce2 | |
| ToppCell | Macroglial-Polydendrocytes-PDGFRA--|Macroglial / cells hierarchy compared to all cells using T-Statistic | 5.25e-05 | 200 | 214 | 7 | cc3409518f8b436ea92deb955e81114b3f410ff7 | |
| ToppCell | Parenchymal-NucSeq-Immune_Lymphocytic-T-T_CD4-CD4_naive/CM|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 5.25e-05 | 200 | 214 | 7 | cded40d5069a6fdbd90ac9a2a0bbef11727b28d5 | |
| ToppCell | LPS_IL1RA-Epithelial_airway-airway_epithelial-Ciliated|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 5.25e-05 | 200 | 214 | 7 | 4992dbf0514d674017315dbd20d91dfec0c608e9 | |
| ToppCell | Macroglial-Polydendrocytes-PDGFRA|Macroglial / cells hierarchy compared to all cells using T-Statistic | 5.25e-05 | 200 | 214 | 7 | c24a3099e3d96d8b72f6d05286bb355d661a0377 | |
| ToppCell | Bronchial-NucSeq-Immune_Lymphocytic-T-T_CD4-CD4_naive/CM|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 5.25e-05 | 200 | 214 | 7 | e0cec0a844b7c1f8edee4c005af27766754e470a | |
| ToppCell | 10x5'v1-week_17-19-Mesenchymal_osteo-stroma|week_17-19 / cell types per 3 fetal stages;per 3',per 5' | 5.25e-05 | 200 | 214 | 7 | 3c898e81444b001835c3f1bbc68183078701b135 | |
| ToppCell | Macroglial-Polydendrocytes-PDGFRA---|Macroglial / cells hierarchy compared to all cells using T-Statistic | 5.25e-05 | 200 | 214 | 7 | 4fc3de4bff7ed2bf40b38462c4b4e9b87af6a4ca | |
| ToppCell | Bronchial-NucSeq-Immune_Lymphocytic-T-T_CD4|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 5.25e-05 | 200 | 214 | 7 | 9de4d6ebb7e9bee5d811519eb05913ef30f70786 | |
| ToppCell | COVID-19|World / Disease, condition lineage and cell class | 5.25e-05 | 200 | 214 | 7 | 7dec470c379cd89f05a0f37c8628b21f136e52f0 | |
| ToppCell | 10x5'v1-week_17-19-Mesenchymal_osteo|week_17-19 / cell types per 3 fetal stages;per 3',per 5' | 5.25e-05 | 200 | 214 | 7 | 3eca8ffeb41b664fbdbbd70b375c5d953503ab29 | |
| ToppCell | Macroglial-Polydendrocytes-PDGFRA----L1-6|Macroglial / cells hierarchy compared to all cells using T-Statistic | 5.25e-05 | 200 | 214 | 7 | 310cd53db1c137f6af74e6ae682221d7ac27310c | |
| ToppCell | LPS-antiTNF-Epithelial_airway-Ciliated_cells-Ciliated|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 8.11e-05 | 148 | 214 | 6 | d61123f0c811287843d066b932b4a9ff09c07c5b | |
| ToppCell | LPS-antiTNF-Epithelial_airway-Ciliated_cells|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 8.11e-05 | 148 | 214 | 6 | c8e93b87212f55774223caa385859c566fa1981f | |
| ToppCell | mild_COVID-19_(asymptomatic)-CD8+_T_naive|World / disease group, cell group and cell class (v2) | 9.40e-05 | 152 | 214 | 6 | f944743f40ff6ed3a7a096dd53e12d3526c67c4d | |
| ToppCell | Control-Epithelial_airway-Ciliated_cells-Ciliated|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.01e-04 | 154 | 214 | 6 | 4e3bc24043144143842627cacf6f90dda2228910 | |
| ToppCell | Control-Epithelial_airway-Ciliated_cells|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.01e-04 | 154 | 214 | 6 | 7556a4b2b062da5ae7ec2bbb66e745e7662db628 | |
| ToppCell | Epithelial-Epithelial-B_(AT1-AT2-progenitors)|Epithelial / shred on cell class and cell subclass (v4) | 1.01e-04 | 154 | 214 | 6 | 770712806e26f73456fb77a81aa4ef8ec78a21ea | |
| ToppCell | mild_COVID-19_(asymptomatic)-CD8+_T_naive|mild_COVID-19_(asymptomatic) / disease group, cell group and cell class (v2) | 1.05e-04 | 155 | 214 | 6 | e2c901d5c9e42d25d7702e5e8fc19b06f7c817be | |
| ToppCell | E16.5-samps-Mesenchymal-Myofibroblast-Migrating_MyoFibroblast|E16.5-samps / Age Group, Lineage, Cell class and subclass | 1.05e-04 | 155 | 214 | 6 | 1882fa5fd25f77d6e3ac47b613f6fb3c67d8e50c | |
| ToppCell | facs-Trachea-24m-Hematologic-myeloid-granulocyte-granulocyte_l26|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.08e-04 | 156 | 214 | 6 | da5cfa8fa9595613f04ce9511f8b42bad34d995a | |
| ToppCell | facs-Thymus-Thymus_Flowthrough-18m-Epithelial|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.16e-04 | 158 | 214 | 6 | 12661763d1c309106801cb710c04cd2b62d16cba | |
| ToppCell | facs-Thymus-Thymus_Flowthrough-18m-Epithelial-TECs|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.16e-04 | 158 | 214 | 6 | 0792c39e6fc0745095af7812de2d50949540d60f | |
| ToppCell | facs-Thymus-Thymus_Flowthrough-18m-Epithelial-epithelial_cell_of_thymus|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.16e-04 | 158 | 214 | 6 | e7db50d6dfaf7280a73a0d5b5aa4f43ea2762d72 | |
| ToppCell | PND01-Epithelial-Epithelial_Airway-Neurosecretory-Secretory-Secretory_mature|PND01 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.24e-04 | 160 | 214 | 6 | 01ae730e9d0d05f3277f862f0c09bafb32b89db5 | |
| ToppCell | PND01-Epithelial-Epithelial_Airway-Neurosecretory|PND01 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.24e-04 | 160 | 214 | 6 | 6de9e7be1d860d82d503bfbc779e72f072a6efc3 | |
| ToppCell | PND01-Epithelial-Epithelial_Airway-Neurosecretory-Secretory|PND01 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.24e-04 | 160 | 214 | 6 | b4844a8c7755a2b2868019791d8d224154973445 | |
| ToppCell | frontal_cortex-Neuronal-GABAergic_neuron-Sst-Sst_Calb2_Pdlim5|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 1.29e-04 | 161 | 214 | 6 | bf70be1de418615b5442ec684552551edaf1f072 | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast-kidney_interstitial_fibroblast|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.29e-04 | 161 | 214 | 6 | a006491c991e6a134be20ad75092a91f3b7c3c91 | |
| Drug | Drofenine hydrochloride [548-66-3]; Up 200; 11.4uM; MCF7; HT_HG-U133A | ZHX3 TRAF2 ZZEF1 INO80D IRF9 PML OSGIN1 VLDLR GTDC1 TRIM3 LTBP2 | 2.30e-06 | 195 | 212 | 11 | 3455_UP |
| Drug | Nafcillin sodium salt monohydrate [7177-50-6]; Down 200; 8.8uM; MCF7; HT_HG-U133A | TRAF2 TBC1D2 PI4K2A KLF4 IRF9 HOXC10 USP7 UTRN VLDLR PCDHA6 THBS3 | 2.30e-06 | 195 | 212 | 11 | 3323_DN |
| Drug | Dimenhydrinate [523-87-5]; Down 200; 8.6uM; HL60; HT_HG-U133A | TRAF2 MYO9B PI4K2A USP7 PML GSTCD TNK2 LTBP2 IL1RAP OGA RASGRP2 | 2.80e-06 | 199 | 212 | 11 | 2400_DN |
| Drug | ICI 182,780; Up 200; 1uM; MCF7; HT_HG-U133A | RAD54L2 PLXNB2 HOXC10 AP5Z1 GYG2 PML OSGIN1 VLDLR ADCK2 ENPP4 | 1.54e-05 | 195 | 212 | 10 | 1630_UP |
| Drug | Paroxetine maleate [64006-44-6]; Down 200; 1uM; PC3; HT_HG-U133A | 1.68e-05 | 197 | 212 | 10 | 4556_DN | |
| Drug | S(+)-Terguride [37686-84-3]; Down 200; 11.8uM; MCF7; HT_HG-U133A | PDE3B MYO9B PI4K2A INO80D IRF9 HOXC10 UTRN ENPP4 OGA CYP4F11 | 1.68e-05 | 197 | 212 | 10 | 5400_DN |
| Drug | Fluorometholone [426-13-1]; Down 200; 10.6uM; MCF7; HT_HG-U133A | TRAF2 ABCA2 MYO9B PI4K2A INO80D IRF9 VPS13A UTRN VPS50 TRIM3 | 1.92e-05 | 200 | 212 | 10 | 6071_DN |
| Drug | Simvastatin [79902-63-9]; Down 200; 9.6uM; MCF7; HT_HG-U133A | ZHX3 PDE3B PI4K2A USP7 SECISBP2 BRD1 PML SMCHD1 LTBP2 IL1RAP | 1.92e-05 | 200 | 212 | 10 | 4828_DN |
| Disease | 1,5 anhydroglucitol measurement | 4.60e-08 | 29 | 207 | 6 | EFO_0008009 | |
| Disease | visceral adipose tissue measurement, body mass index | 1.86e-07 | 87 | 207 | 8 | EFO_0004340, EFO_0004765 | |
| Disease | Abnormality of refraction | ZHX3 ABCA4 CDK12 TKTL1 ZZEF1 STK35 ZGPAT TJP2 UTRN FAT3 PCDHA10 PCDHA7 PCDHA6 PCDHA4 PCDHA2 PCDHA1 CHST1 CTNNA2 | 1.44e-06 | 673 | 207 | 18 | HP_0000539 |
| Disease | Van Maldergem Wetzburger Verloes syndrome | 4.90e-05 | 2 | 207 | 2 | C1832390 | |
| Disease | Van Maldergem syndrome | 4.90e-05 | 2 | 207 | 2 | cv:C1832390 | |
| Disease | Periventricular gray matter heterotopia | 4.90e-05 | 2 | 207 | 2 | C1849173 | |
| Disease | vital capacity | TNFSF12 CDK12 ZZEF1 ZGPAT CEP120 ATAD2B UTRN PID1 NPNT DIP2B CACNA1S PCDHA10 PCDHA7 PCDHA6 PCDHA4 PCDHA2 PCDHA1 THBS2 GSTCD LTBP2 CTNNA2 OTOG | 6.27e-05 | 1236 | 207 | 22 | EFO_0004312 |
| Disease | pulse pressure measurement | TNFSF12 TTC16 PLXNB2 PLEKHG1 CEP120 ATAD2B BRD1 NPNT DIP2B CUX2 FAT3 PCDHA10 PCDHA7 PCDHA6 PCDHA4 PCDHA2 PCDHA1 CWC22 VAC14 THBS2 RBPMS2 LTBP2 CTNNA2 | 1.29e-04 | 1392 | 207 | 23 | EFO_0005763 |
| Disease | Heterotopia, Periventricular, Autosomal Recessive | 1.46e-04 | 3 | 207 | 2 | C1842563 | |
| Disease | post-traumatic stress disorder symptom measurement | 2.85e-04 | 82 | 207 | 5 | EFO_0008535 | |
| Disease | abdominal adipose tissue measurement | 5.26e-04 | 53 | 207 | 4 | EFO_0803316 | |
| Disease | lateral orbital frontal cortex volume measurement | 6.18e-04 | 24 | 207 | 3 | EFO_0010312 | |
| Disease | neuroticism measurement, cognitive function measurement | SEMA6D HTR6 PCDHA10 PCDHA7 PCDHA6 PCDHA4 PCDHA2 PCDHA1 DENND1A VAC14 LONRF2 OGA | 7.03e-04 | 566 | 207 | 12 | EFO_0007660, EFO_0008354 |
| Disease | platelet crit | TNFSF12 MYO9B BACH2 PDE10A STK35 NUP205 ZGPAT USP7 OSGIN1 PGBD2 DIP2B VLDLR C2CD2 P2RX1 RBPMS2 DCHS1 | 1.18e-03 | 952 | 207 | 16 | EFO_0007985 |
| Disease | cholesteryl esters to total lipids in large LDL percentage | 1.32e-03 | 31 | 207 | 3 | EFO_0022249 | |
| Disease | lifestyle measurement, alcohol consumption measurement | 1.33e-03 | 115 | 207 | 5 | EFO_0007878, EFO_0010724 | |
| Disease | Syndactyly | 1.33e-03 | 8 | 207 | 2 | C0039075 | |
| Disease | Schizophrenia | SRSF10 ABCA13 MYO9B LAMA1 PTPRA CEACAM21 AKT1 BRD1 PML VLDLR HTR6 FZD3 SIRT1 DAAM2 CTNNA2 | 1.51e-03 | 883 | 207 | 15 | C0036341 |
| Disease | colorectal adenoma | 1.59e-03 | 33 | 207 | 3 | EFO_0005406 | |
| Disease | Osteitis Deformans | 1.71e-03 | 9 | 207 | 2 | C0029401 | |
| Disease | hyperthyroidism | 1.89e-03 | 35 | 207 | 3 | EFO_0009189 | |
| Disease | Chronic Kidney Diseases | 2.12e-03 | 10 | 207 | 2 | C1561643 | |
| Disease | alcohol drinking | 2.57e-03 | 81 | 207 | 4 | EFO_0004329 | |
| Disease | Jeune thoracic dystrophy | 2.58e-03 | 11 | 207 | 2 | C0265275 | |
| Disease | invasive ductal carcinoma (is_implicated_in) | 2.58e-03 | 11 | 207 | 2 | DOID:3008 (is_implicated_in) | |
| Disease | Cognitive impairment | 2.58e-03 | 11 | 207 | 2 | HP_0100543 | |
| Disease | ovarian neoplasm | 2.60e-03 | 134 | 207 | 5 | C0919267 | |
| Disease | apolipoprotein A 1 measurement | TTC39B PDE3B MAN2A2 TNFSF12 NUP205 IRF9 NFATC3 NLRC5 AKT1 AKNA PIM3 CELSR2 VPS53 TP53BP1 | 2.79e-03 | 848 | 207 | 14 | EFO_0004614 |
| Disease | Malignant neoplasm of ovary | 2.86e-03 | 137 | 207 | 5 | C1140680 | |
| Disease | retinitis pigmentosa (is_implicated_in) | 2.98e-03 | 41 | 207 | 3 | DOID:10584 (is_implicated_in) | |
| Disease | autistic disorder (is_marker_for) | 3.09e-03 | 12 | 207 | 2 | DOID:12849 (is_marker_for) | |
| Disease | post-traumatic stress disorder | 3.11e-03 | 202 | 207 | 6 | EFO_0001358 | |
| Disease | physical activity | 3.47e-03 | 88 | 207 | 4 | EFO_0003940 | |
| Disease | lobe attachment | 3.51e-03 | 207 | 207 | 6 | EFO_0007667 | |
| Disease | body weight | ZZEF1 ZGPAT OPTC TFCP2L1 CEP120 SEMA6D UNC13B CUX2 POLR1A SMCHD1 PCDHA1 HUWE1 TEX11 TRIM27 CWC22 DENND1A LTBP2 CTNNA2 | 3.53e-03 | 1261 | 207 | 18 | EFO_0004338 |
| Disease | osteitis deformans | 3.63e-03 | 13 | 207 | 2 | EFO_0004261 | |
| Disease | testosterone measurement | ZHX3 TNFSF12 MYO9B CEP120 SEMA6D USP7 UTRN OSGIN1 RAF1 DIP2B CUX2 POLR1A DNAH2 AKNA CWC22 C2CD2 KNDC1 DAAM2 | 3.96e-03 | 1275 | 207 | 18 | EFO_0004908 |
| Disease | Acute Promyelocytic Leukemia | 4.14e-03 | 46 | 207 | 3 | C0023487 | |
| Disease | Colorectal Carcinoma | ABCA4 ABCA13 LAMA1 KMT2C SACS VPS13A PCDH11X AKT1 UNC13B TYMP DCHS1 LONRF2 | 4.18e-03 | 702 | 207 | 12 | C0009402 |
| Disease | Prostatic Neoplasms | CDK12 TBC1D2 ETV4 KMT2C FAF2 USP7 AKT1 PML SIRT1 DHX30 GSTCD | 4.37e-03 | 616 | 207 | 11 | C0033578 |
| Disease | Malignant neoplasm of prostate | CDK12 TBC1D2 ETV4 KMT2C FAF2 USP7 AKT1 PML SIRT1 DHX30 GSTCD | 4.37e-03 | 616 | 207 | 11 | C0376358 |
| Disease | Celiac Disease | 4.40e-03 | 47 | 207 | 3 | C0007570 | |
| Disease | multisite chronic pain | 4.55e-03 | 95 | 207 | 4 | EFO_0010100 | |
| Disease | Squamous cell carcinoma of esophagus | 4.55e-03 | 95 | 207 | 4 | C0279626 | |
| Disease | Adenocarcinoma of large intestine | 4.73e-03 | 96 | 207 | 4 | C1319315 | |
| Disease | N-acetylmethionine measurement | 4.84e-03 | 15 | 207 | 2 | EFO_0021427 | |
| Disease | aspartate aminotransferase measurement | ABCA4 TNFSF12 STK35 ZGPAT C19orf12 NGF NLRC5 CACNA1S CUX2 DNAH2 AKNA ARSA PCDHGB4 CTNNA2 | 4.88e-03 | 904 | 207 | 14 | EFO_0004736 |
| Disease | cholesteryl esters to total lipids in small VLDL percentage | 4.94e-03 | 49 | 207 | 3 | EFO_0022256 | |
| Disease | neutrophil count, basophil count | 5.14e-03 | 224 | 207 | 6 | EFO_0004833, EFO_0005090 | |
| Disease | intracerebral hemorrhage | 5.51e-03 | 16 | 207 | 2 | EFO_0005669 | |
| Disease | Alzheimer disease, gastroesophageal reflux disease | 5.60e-03 | 228 | 207 | 6 | EFO_0003948, MONDO_0004975 | |
| Disease | interleukin 12 measurement | 6.16e-03 | 53 | 207 | 3 | EFO_0004753 | |
| Disease | Psychoses, Substance-Induced | 6.21e-03 | 17 | 207 | 2 | C0033941 | |
| Disease | aspartate aminotransferase to alanine aminotransferase ratio | 7.00e-03 | 239 | 207 | 6 | EFO_0010934 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| RPQDVDQREAPLNNF | 41 | P31749 | |
| ANERFAVPEILFNPS | 271 | Q9GZN1 | |
| PFPVDQITDLPRNDF | 616 | Q9BYV9 | |
| DQLQDKDPARIFAQP | 576 | O95696 | |
| PTRAAAAVNFFNIDP | 411 | P50406 | |
| AAVNFFNIDPAEPEL | 416 | P50406 | |
| RKPPENLADQSFLER | 261 | Q7Z695 | |
| QFPGDQDLRFARVPL | 1396 | Q9NYV4 | |
| LPPAEQQRLFNEAAA | 91 | Q9NSK7 | |
| EDALAQQFEQPDPAR | 426 | Q8NAG6 | |
| LDPRETQDLPARAFS | 456 | Q8NAG6 | |
| DDLLPDLNPVEQFFQ | 2176 | P78363 | |
| RASDQSDFREQQPPA | 266 | Q3KPI0 | |
| RDLNDNAPVFPDPSI | 126 | Q6V0I7 | |
| ESFQNRLLAFPEESP | 661 | Q86UQ4 | |
| RLLAFPEESPCFEEN | 666 | Q86UQ4 | |
| GAFRLAAENPFQEPR | 96 | Q9NUS5 | |
| RAPSCLEAFRDPQFQ | 501 | O43299 | |
| RNDNPPVLGNFEILF | 1016 | Q9HCU4 | |
| PEEENVFLAPQLARA | 256 | Q9Y4B4 | |
| DDDSAIRALTQFPLP | 231 | Q7L2E3 | |
| FEAARSLDDRLQPPS | 106 | O14529 | |
| LRTPDVDNPEQPFDA | 661 | Q9Y485 | |
| PTFVALRDFLLEAQP | 376 | Q07912 | |
| AFPPRSVAQFQAERA | 231 | Q16671 | |
| AFPDNQRPALKAEFD | 431 | P43268 | |
| DPTPEQFQAFRNEVA | 381 | P04049 | |
| IRFDPENPQTLRLEF | 91 | Q6ZRY4 | |
| EDFRQLPEEDFRQPP | 641 | Q8IXT5 | |
| AAGENPLEFLRDQPQ | 226 | P54725 | |
| PEPLQLDFFDRAQIE | 1196 | Q92621 | |
| SDRPVLSDPQAELQF | 676 | Q9Y5F9 | |
| DDRNDNAPRVLYPAL | 551 | Q9UN71 | |
| LISDVNDNPPIFRED | 441 | Q9Y5F3 | |
| LDENDNAPALLAPRA | 556 | Q9Y5H9 | |
| LDENDNAPALLAPRV | 556 | Q9UN73 | |
| TQADLSRNRFPEVPE | 71 | O75427 | |
| PFNCNRLPEAADLEA | 561 | Q9BY79 | |
| LDENDNAPALLAPRV | 556 | Q9UN72 | |
| PIPNAEELNIRFAEL | 41 | Q86T65 | |
| RVLLDDVNDNSPAFP | 881 | Q96JQ0 | |
| ADLQDFLSRIFQVPP | 641 | Q6Y2X3 | |
| SNLAPLPRRETEEFN | 86 | O43474 | |
| NEPTDEFSDLPLRVA | 326 | Q96II8 | |
| PVFQRLFLESSDANP | 121 | Q9NU22 | |
| IRQRSEPFFPNIDFD | 3076 | Q8NEZ4 | |
| PLSPLDERANALVQF | 1016 | Q9UJ55 | |
| TQPPREAADTQDLDF | 91 | P01138 | |
| FPAEFDLNPELAEQI | 86 | Q7LDG7 | |
| PQEEEEFRRLAALPN | 316 | P33992 | |
| FIPRQPSNDLFEIFE | 386 | Q6UXI9 | |
| DRDLEEPINFRLPEN | 76 | Q9NPH3 | |
| DDSDIFNQPPNRERP | 836 | O60303 | |
| NFRIDALLAVDPPRA | 6 | P50219 | |
| PGRFDREFLFNLPDQ | 561 | Q9ULI0 | |
| QPPSEDSDQERLFEL | 396 | Q5SZK8 | |
| ETLQPFFEGLLPRDN | 606 | Q9HCG8 | |
| PPFRSPERDQDELFN | 551 | Q9C098 | |
| ERERPQPVQAFSSAL | 261 | Q9H425 | |
| PPLQAVLVADSFDRR | 41 | Q13144 | |
| PDLRPQAQANFFDLE | 131 | P38570 | |
| FFRVVPQRLPGADQE | 176 | Q5NUL3 | |
| PDPDNTFLSRLNEFL | 96 | Q96BY2 | |
| REDVFPANALLEIRP | 126 | Q7Z2X4 | |
| ENPVLRAFEPLRSFA | 981 | O15031 | |
| FEVLPLRNDVLNPDN | 41 | Q9UBM4 | |
| LNIPDAYADPRFNRE | 341 | Q9Y233 | |
| NRSPIEFPDTADFLN | 531 | Q13370 | |
| TNPERDGPDRFQFEL | 646 | Q08493 | |
| RPFSRLQLQEDDDDP | 436 | Q9Y6X5 | |
| TDLQVPPTADRFQAE | 316 | P13942 | |
| DVFANTRIENFSAPP | 206 | Q9P265 | |
| PPDRLVLASIDQADF | 656 | P05129 | |
| RQFPDDVEDAPDLNA | 401 | Q1L5Z9 | |
| AVARPPNIVLIFADD | 16 | P15289 | |
| PVFVPDVALIANRFN | 146 | Q8NAT1 | |
| DEVQVFAPANALPAR | 126 | Q96FE7 | |
| RFLIEDINDNAPLFP | 126 | Q9BZA7 | |
| FSRPQIDENPLDDNS | 356 | Q5F1R6 | |
| FDPSPEDIARADNIF | 71 | Q8N3Z3 | |
| DNSRDIEVASNPAFP | 1636 | P42694 | |
| PPDIAAEAQALRREQ | 3086 | Q7Z6Z7 | |
| QDDAPFPALLAQEDV | 276 | C9JSJ3 | |
| AANRLGDPLEAFPVF | 31 | Q86UY6 | |
| LEFPRQEENPEAVAL | 1426 | Q86WI3 | |
| SQEPRLDFAFFDNQP | 1846 | Q86WI3 | |
| LDENDNAPALLAPRV | 556 | Q9Y5I3 | |
| VLDANDNAPIFDRPV | 231 | Q9Y5I2 | |
| RFEAEPLPENTNRQL | 276 | Q9BTU6 | |
| EEQRSPFNDRFPLKR | 701 | O94913 | |
| FDPQPADASRNLVLI | 161 | Q96HP4 | |
| VEILDINDNSPRFPR | 136 | Q9Y5I4 | |
| EVRSRPPLQDDLLFF | 96 | Q15390 | |
| LPFRNCPRFQELESE | 156 | P15309 | |
| LDENDNAPALLAPRA | 556 | Q9UN74 | |
| TFEPSQELPAEALRD | 426 | O15488 | |
| QDFVATNLEPRFIEP | 3641 | Q9P2D7 | |
| FIRTQFDDNPDARLP | 2016 | Q9C0G6 | |
| LFTAPFPQDSDELER | 2226 | Q9ULT8 | |
| PFLSFEEDPRQQALE | 96 | Q9Y426 | |
| PLQARADEVAAAPEQ | 21 | P59665 | |
| PQPFEENEFIDASRL | 601 | P26232 | |
| ERFAAATPNRNLPTD | 251 | O75553 | |
| ATPNRNLPTDFDEIF | 256 | O75553 | |
| PLQARADEVAAAPEQ | 21 | P59666 | |
| DFPQDPRTNPLARAN | 1646 | Q13698 | |
| DFVRPLNINPDRALG | 191 | Q96MA1 | |
| NDLINPNFEPERASV | 236 | Q8N960 | |
| RDPRAALQEATFDPQ | 946 | Q9P218 | |
| FLLEARNAEDLNGPP | 76 | Q6ZNA5 | |
| DPFRFDQENIKERSP | 441 | Q9HBI6 | |
| QDFTDLIAQPPDSVR | 381 | Q8WXX0 | |
| VLDINDNPPVFERRD | 3226 | Q8TDW7 | |
| EEALQRPVASDFEPQ | 26 | P00519 | |
| LSLDELPPALRQDNF | 531 | Q9BZC7 | |
| LFPNATSPELLEDFR | 46 | Q7Z591 | |
| DARIFLNEIPPFVED | 191 | Q9P2S6 | |
| RLVQAFERNPFPDIA | 116 | A0A1W2PPF3 | |
| VIPDEEFDPQNSRLA | 221 | Q14767 | |
| EAPFEQRASLNPRAE | 171 | Q9NYD6 | |
| FDPEAPFLQVDDTRL | 616 | P49641 | |
| APQQARDPFEDLLQK | 966 | Q8TEH3 | |
| VLQEPDFAQSLLRDP | 526 | Q9NPG1 | |
| LNQEDFSDVLPRLPD | 616 | Q53TQ3 | |
| FSDVLPRLPDDLQDF | 621 | Q53TQ3 | |
| FQGDQRSLEFLLPPE | 201 | Q00978 | |
| NPREAEEDARPFNAL | 1386 | Q76NI1 | |
| ALPFQPEQRDSEDLL | 201 | Q4AE62 | |
| RADRPSSLPLDFNDE | 236 | Q96HH9 | |
| LRAAARVAPFPFEDV | 321 | Q7Z7M8 | |
| EPQDFQDDPDIIAFR | 381 | Q9UJW0 | |
| RAGDPNFNIVREFPL | 2106 | Q9P225 | |
| FFPNIQEIEAELRDP | 2061 | Q9NZJ4 | |
| LAIENFLRESSDQPP | 156 | Q8NEC7 | |
| RRAVDDPGLVFNQLP | 316 | Q9UJX0 | |
| FREEFNALPACPIQA | 241 | P18433 | |
| PDVVSLEAADRPNFF | 1306 | Q6ZRI0 | |
| DAQPDALFERTRAPR | 956 | Q6ZN16 | |
| FPDQPFIALEDRRGF | 61 | Q9NPB1 | |
| DDIPRPALLREAENF | 171 | P51575 | |
| PDVFRNACQAFPLDL | 856 | Q9Y2M0 | |
| IAFQPLAEEASFRRP | 66 | Q9UBD0 | |
| TSELNPFSDPRQFDR | 236 | Q13761 | |
| DQARVFLADQPIEAP | 2621 | P46939 | |
| DFAPLTPNIVRALND | 6 | Q08AM6 | |
| DLPDNPERFNLFPCV | 346 | P14373 | |
| ILNRFLEENPDPSAS | 141 | O95602 | |
| DPVFARDLLTFPDNV | 1806 | A6NHR9 | |
| RLLPIDGANDLFFQP | 691 | O60502 | |
| ADPQAEDRPLVFFDL | 601 | P29590 | |
| EFLNPRVLQASREAP | 116 | Q8IXR5 | |
| STRLEFPDFPIDDNR | 2186 | P25391 | |
| ESPEKFQIEANFPRR | 396 | Q96CS3 | |
| FENLFNLLLPRDPED | 416 | Q6P5W5 | |
| DRDPTVFAPILNFLR | 66 | Q8TBC3 | |
| ARLAVDFPDLPDPQA | 281 | Q96EB6 | |
| EAAPRDFCQRFPALE | 271 | B8ZZ34 | |
| PRIEDAEEFPNLAVA | 401 | Q96T21 | |
| DDLPPSRFVQQAEES | 111 | Q92968 | |
| ARLQLVEFSAFVEPP | 226 | Q15562 | |
| LFFLNLNEPDNPADL | 211 | Q8NEZ3 | |
| EILREQPDNIPAFAA | 26 | Q15506 | |
| PLEPFASLEQNREEA | 396 | Q6IE81 | |
| LEPNPDQRFSQLSDV | 261 | Q8WU08 | |
| LDPRASPTQLNAVEF | 141 | Q9NZI6 | |
| DIADNPVENIIRFFP | 86 | Q8WUJ0 | |
| REEIQDASQLPPAFD | 156 | Q9H7B4 | |
| VGNLLEFLAPRDPAQ | 236 | Q6UX72 | |
| LAQEPAADQEVPRDA | 281 | Q9NRA8 | |
| PAPLEDIAEQIFNAA | 121 | Q8WUX2 | |
| NPSVSLVEERDFRPF | 396 | O43916 | |
| NKNFREEEPRPDSFL | 81 | Q16280 | |
| NNNREEIFIAPPDNA | 36 | Q6P3X8 | |
| FPDNAARREVESLPA | 91 | Q12933 | |
| EFRELREQPSDPQAE | 36 | Q96JG6 | |
| AANPQDRPDAFELET | 511 | Q8TDR2 | |
| ALQASPPLDQDDRAF | 126 | Q9UDY2 | |
| SEVESLRPPRFFNED | 3031 | Q96RL7 | |
| AEAERLLAPFLQQFP | 376 | Q5VTQ0 | |
| LFVDPDDPTQNRNRI | 131 | Q96BF3 | |
| RNFQLPEDLEDQEPR | 161 | Q96CM4 | |
| RPPNTSLFVRNVADD | 6 | O75494 | |
| GPEEFIQRFLPRELQ | 46 | Q96PN8 | |
| ASQPDPNRFDRDRLF | 66 | Q9Y5S1 | |
| LQPQRAALAPSFVEF | 1011 | Q6ZS81 | |
| LPPDLRDFVEEDNQR | 681 | Q9UHP3 | |
| LQINDPEREFLERPS | 131 | Q12968 | |
| NDNSPNIPEAIDRLF | 36 | Q8IYF3 | |
| RNNFPAGSPERLQDL | 876 | O14795 | |
| ALRRSDSPEIPFQAA | 1456 | Q12888 | |
| LVLERPEPAQDLFDF | 121 | Q86V86 | |
| PEDFEPFRRQLLQGR | 941 | P49746 | |
| AIEQVFPSQDPLDRA | 26 | Q5VIR6 | |
| FPSQDPLDRADFNAV | 31 | Q5VIR6 | |
| QLPDNPERFDQSATV | 316 | Q8N9V2 | |
| ATNFPEALDNALIRP | 481 | Q96TA2 | |
| FPLSVVQREPARDAA | 276 | Q96NZ8 | |
| FRPIAVELEFENQPL | 131 | Q0IIN9 | |
| PEATRVAFLLLDNPA | 96 | Q86WT1 | |
| PNDLAFFVDIQLPDL | 1691 | O43149 | |
| QFPPSELAREAAAQQ | 301 | Q96BZ9 | |
| EESQDPAPFLNRLVR | 76 | O43508 | |
| RAIENNPLDPSLFLF | 276 | Q8NEE8 | |
| ALFPSRRSPQENEDD | 541 | Q9ULL1 | |
| PDDRDNCRLVFNPDQ | 906 | P35442 | |
| SQLRAVSFPEDDEPL | 16 | Q8NFY4 | |
| FPSDAPLEEARQFAA | 336 | Q92575 | |
| FAQNPLPLDEELDRL | 631 | Q9H4I2 | |
| INDRFEFPEQLPLDE | 421 | Q93009 | |
| QEALVLSDRAPFAAP | 456 | P19971 | |
| ELRPFQDPDLSSLQA | 206 | Q8N5A5 | |
| DPENPDNDRFVLAKR | 71 | P51854 | |
| SPLRPDAANRDFLSQ | 436 | Q9BYX2 | |
| DAASEPLRRPNFQFL | 206 | A6NP61 | |
| EEEARFSSQQPPAQL | 171 | O60304 | |
| ERLAALAAQAFPERP | 276 | O75382 | |
| APPEVDFDRLLASLQ | 191 | Q5T124 | |
| FNSDLREPASIAVDP | 551 | P98155 | |
| INNSLDEPRAIAVFP | 1466 | O75096 | |
| IDPQRVRKPNDLEAF | 321 | Q8N145 | |
| LLERTFLNPRAFPEE | 661 | Q9UQQ1 | |
| LPRQQADFDDLCNLP | 141 | Q13459 |